Get the latest news on drug recalls, safety alerts, new therapies and other important updates.
October 9, 2020
Sun Pharma is voluntarily recalling one lot of RIOMET ER™ (metformin hydrochloride extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to the level of N-Nitrosodimethylamine (NDMA), which has been found to be above the allowable Acceptable Daily Intake (ADI) limit established by the U.S. Food and Drug Administration.
October 2, 2020
Acella Pharmaceuticals, a company that makes NP thyroid tablets, a drug used to treat hypothyroidism (underactive thyroid), is voluntarily recalling certain lots of this medicine.
May 4, 2020
The Food and Drug Administration (FDA) has issued a recall for nizatidine oral solution, a drug used for the short-term treatment (up to 8 weeks) of active duodenal ulcers and active benign gastric ulcers, as maintenance therapy for duodenal ulcer patients for up to one year, and for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis and associated heartburn due to gastroesophageal reflux disease (GERD).
April 30, 2020
The Food and Drug Administration (FDA) has issued a recall for tetracycline, a drug used to treat infections including upper and lower respiratory infections and skin and soft tissues infections.
April 13, 2020
The Food and Drug Administration (FDA) has issued a recall for all ranitidine products, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable.
March 4, 2020
The manufacturer of phenytoin is voluntarily recalling this medicine because it may not re-suspend when shaken, which could result in under or over-dosing
February 21, 2020
The Food and Drug Administration (FDA) has issued a voluntary recall of lorcaserin drugs due to an impurity used in the manufacturing of these medicines.
January 29, 2020
The Food and Drug Administration (FDA) has issued a voluntary recall of nizatidine drugs due to an impurity used in the manufacturing of these medicines.
January 16, 2020
The FDA continues to monitor and may add more manufacturers to the recall for ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable.
September 26, 2019
The manufacturer of NATPARA, a drug used to treat hypocalcemia in patients with hypoparathyroidism, is issuing a recall of all doses on the market because of a potential issue.
January 21, 2019
The Food and Drug Administration (FDA) has issued a voluntary recall of select irbesartan-containing drugs due to an impurity used in the manufacturing of these medicines.
January 4, 2019
The Food and Drug Administration (FDA) has issued a voluntarily recall of select losartan containing drugs due to an impurity used in the manufacturing of these medicines.
November 20, 2018
The Food and Drug Administration (FDA) has issued a voluntary recall of select generic valsartan and valsartan containing drugs due to an impurity used in the manufacturing of these medicines.
August 6, 2018
Novartis and Sandoz Inc. have voluntarily recalled certain blister card packages distributed in the U.S.
June 1, 2017
The maker of Ventolin HFA Inhaler® has voluntarily recalled select lots from the U.S. marketplace. This recall was initiated due to a defect in certain lots of the inhaler that causes the product to deliver fewer doses than indicated.
June 1, 2017
The maker of EpiPen® and EpiPen Jr® Auto-Injectors has voluntarily recalled selected lots distributed in the U.S. and other markets. This recall was initiated due to reports of possible device malfunctions that could result in the devices failing to activate or requiring increased force to activate in an emergency or life-threatening situation.